Literature DB >> 26349125

Erosion Prevention Potential of an Over-the-Counter Stabilized SnF2 Dentifrice Compared to 5000 ppm F Prescription-Strength Products.

S L Eversole, K Saunders-Burkhardt, R V Faller.   

Abstract

OBJECTIVE: To determine the relative ability of various F-containing products to protect enamel against the initiation and progression of tooth surface loss due to erosive acid challenges.
METHODS: Cores of enamel were prepared from extracted human teeth, soaked in pooled human saliva (pellicle formation), and then treated in a 1:3 slurry (product:saliva) of either OTC level (1100 ppm F) or prescription level (5000 ppm F) products, followed by a standardized erosion cycling procedure (five days of cycling) that included 10-minute challenges with an erosive dietary acid (1% citric acid at pH 2.3) applied 60 minutes after each dentifrice treatment (repeated four times per day). Enamel surface loss was measured using transverse microradiography. Two studies were conducted. Study 1 included: A) 1100 ppm F as NaF; B) 1100 ppm F as stabilized SnF; C) 5000 ppm F as NaF; and D) 5000 ppm F as NaF + acidulated phosphate. Study 2 included: 1) 1100 ppm F as stabilized SnF; 2) 5000 ppm F as NaF + tricalcium phosphate; and 3) 1100 ppm F as NaF.
RESULTS: Study 1: Treatment B (1100 ppm F as SnF), where specimens lost only 8.0 μm of the enamel surface, was significantly more effective than Treatments A, C, and D at protecting enamel against the initiation and progression of erosive acid damage (p < 0.05). Specimens treated with product A exhibited 22.8 (1.25) μm (mean ± sem) of enamel loss; 20.0 (0.71) μm of enamel loss with treatment C and 24.0 (1.4) μm of enamel loss with Treatment D. Study 2 also demonstrated significantly greater erosion protection with the stabilized SnF2 dentifrice (p < 0.05), with only 5.8 (1.93) μm of tooth surface loss, while groups 2 and 3 lost 19.8 (0.75) μm and 18.0 (2.16) μm, respectively.
CONCLUSION: Results from both studies demonstrated the OTC dentifrice formulated with stabilized SnF2 provides significantly greater protection against erosive acid attack compared to some of the most popular prescription level (5000 ppm F) fluoride treatments available.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26349125

Source DB:  PubMed          Journal:  J Clin Dent        ISSN: 0895-8831


  6 in total

1.  A Novel Small Molecule, ZY354, Inhibits Dental Caries-Associated Oral Biofilms.

Authors:  Chenzi Zhang; Xinyi Kuang; Yuanzheng Zhou; Xian Peng; Qiang Guo; Tao Yang; Xuedong Zhou; Youfu Luo; Xin Xu
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  Impact of customary fluoride rinsing solutions on the pellicle's protective properties and bioadhesion in situ.

Authors:  A Kensche; J Kirsch; S Mintert; F Enders; S Pötschke; S Basche; B König; C Hannig; M Hannig
Journal:  Sci Rep       Date:  2017-11-29       Impact factor: 4.379

3.  Ecological Effect of Arginine on Oral Microbiota.

Authors:  Xin Zheng; Jinzhi He; Lin Wang; Shuangshuang Zhou; Xian Peng; Shi Huang; Liwei Zheng; Lei Cheng; Yuqing Hao; Jiyao Li; Jian Xu; Xin Xu; Xuedong Zhou
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

4.  Randomized in situ clinical trial evaluating erosion protection efficacy of a 0.454% stannous fluoride dentifrice.

Authors:  Nicola X West; Tao He; Nikki Hellin; Nicholas Claydon; Joon Seong; Emma Macdonald; Svetlana Farrell; Rachelle Eusebio; Aneta Wilberg
Journal:  Int J Dent Hyg       Date:  2019-02-19       Impact factor: 2.477

5.  Repurposing Napabucasin as an Antimicrobial Agent against Oral Streptococcal Biofilms.

Authors:  Xinyi Kuang; Tao Yang; Chenzi Zhang; Xian Peng; Yuan Ju; Chungen Li; Xuedong Zhou; Youfu Luo; Xin Xu
Journal:  Biomed Res Int       Date:  2020-11-20       Impact factor: 3.411

6.  Antimicrobial activities of a small molecule compound II-6s against oral streptococci.

Authors:  Jin Zhang; Xinyi Kuang; Yuanzheng Zhou; Ran Yang; Xuedong Zhou; Xian Peng; Youfu Luo; Xin Xu
Journal:  J Oral Microbiol       Date:  2021-03-30       Impact factor: 5.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.